companies / tenpointtx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-19 json
| total_raised | 120,000,000120.0M | ○ |
|---|---|---|
| founded | 2017 | |
| hq | San Diego | |
| industry | unknown | |
| stage | series-b+ |
Tenpoint Therapeutics is a biopharmaceutical company developing treatments for age-related vision conditions including presbyopia, cataracts, and geographic atrophy. It serves patients with age-related near vision loss. Its differentiator is optimizing for functional near vision, all-day duration of effect, and long-term tolerability.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-01-29 | series-b | 85,000,00085.0M | null | ○ |
Nginx, WordPress, Yoast SEO 27.3, Google Tag Manager, jQuery Migrate 3.4.1, jsDelivr, Elementor 4.0.1, Pantheon, CookieYes, Varnish, PHP, MariaDB
| fact | status | src |
|---|---|---|
| Series B, $85.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |